Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants

The novel mechanisms of action (MOA) derived from some recently introduced molecular targets have led to regulatory approvals for rapid acting antidepressants (RAADs) that can generate responses within hours or days, rather than weeks or months. These novel targets include the N-methyl-D-glutamate r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yavorsky, Christian, Ballard, Elizabeth, Opler, Mark, Sedway, Jan, Targum, Steven D., Lenderking, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272853/
https://www.ncbi.nlm.nih.gov/pubmed/37333908
http://dx.doi.org/10.3389/fpsyt.2023.1135828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272853/
https://www.ncbi.nlm.nih.gov/pubmed/37333908
http://dx.doi.org/10.3389/fpsyt.2023.1135828

Ejemplares similares